AVR 1.29% $18.31 anteris technologies ltd

As a shareholder of Admedus we eagerly await and review each...

  1. 152 Posts.
    lightbulb Created with Sketch. 9
    As a shareholder of Admedus we eagerly await and review each quarterly in detail. How many people scan through the hundreds of quarterlies that have been released this week for listed companies on the ASX to take a position. The sheep are awaiting bigger blue sky news before taking and committing there hard earned.

    All you need to do is take a look back to October 17 last year when we received FDA clearance for VascuCel and we traded 38million shares that day. For the long term holders that is 380million shares traded pre consolidation. We all knew that the FDA clearance was going to be a given yet when it was announced the broader market took notice.

    What do you think they will do next week when they read about the news from the great professor....... This news is going to be a little more impressive than receiving FDA clearance for VasuCel, a product that was always going to get it. It will gain much more exposure through the media than VasuCel did.

    Current shareholders just need to be patient. The sheep will come and in droves.

    SchafherdeInKoeln.jpg SchafherdeInKoeln.jpg
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$18.31
Change
-0.240(1.29%)
Mkt cap ! $351.9M
Open High Low Value Volume
$18.80 $19.15 $18.20 $159.7K 8.611K

Buyers (Bids)

No. Vol. Price($)
1 73 $18.31
 

Sellers (Offers)

Price($) Vol. No.
$18.33 90 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.